Headquarters: Cambridge, Massachusetts, United States
Trade prices
Volume:
Market Cap:10B
Prev closed:13.36
Open:13.87
High:13.91
Low:13.37
52 week low:9.18
52 week high:19
Dividends:No Dividends
Next ER:November 4, 2021 Before Market Opens
Top Stories (NTLA)
About the Company
Intellia Therapeutics is a biotechnology company developing biopharmaceuticals using a CRISPR gene editing system invented by Jennifer Doudna and colleagues at University of California. The company has partnerships with Novartis and Regeneron.
Talk about Intellia Therapeutics Inc below in comments section below.
Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Technical analysis is a collection of techniques designed to help you make trading decisions in securities markets. Technical Analysis For Dummies helps you take a hard-headed look at what securities prices are actually doing rather than what economists or analysts say they should be doing, giving you the know-how to use that data to decide whether to buy or sell individual securities.
A simple, straightforward guide to the fundamentals of technical analysis
